MeiraGTx meiragtx.com

MeiraGTx (NASDAQ:MGTX) is committed to the development of gene therapies to transform the lives of patients suffering from acquired and inherited disorders. The company focuses on the use of gene therapy to treat devastating neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). MeiraGTx is developing gene therapies for ocular diseases including rare inherited blindness and age-related macular degeneration (AMD). MeiraGTx i...Show all

MeiraGTx (NASDAQ:MGTX) is committed to the development of gene therapies to transform the lives of patients suffering from acquired and inherited disorders. The company focuses on the use of gene therapy to treat devastating neurodegenerative disease...Show all

See All Exits Recent Exits

Phone: 646-490-2965

Fax:

450 E 29th St

New York, 10016
New York, United States

MeiraGTx - Investments & Acquisitions

Show Real Data MeiraGTx Investments
See all Recent Investments
Date Company Round Amount Co-investors
2018-10-09Vector NeurosciencesAcquired
See all 1 investments